The Story
News Summary
- Johnson & Johnson proposed a $5.5 billion settlement to resolve around 76,000 ovarian cancer talc lawsuits.
- Requiring 95% claimant approval, the deal removes major legal uncertainty, backed by J&J's strong balance sheet, though final costs could potentially increase.
Explore US30 price history & advisor snapshot
These are separate market snapshots and may predate this story. Check the data period, generation time and expiry before using them in your research.
Stored market data
US30 price history
51778.04
+9.49% over the displayed period
Advisor Snapshot
Unlock Member-Only Insights
Reserved for TradingNews24 members. Log in or create a free account to access market signals and exclusive tools.